No single vitamin has been proven to cure or reliably prevent cancer, but certain vitamins do influence cancer risk and survival in meaningful ways. The strongest evidence supports vitamin D for reducing cancer mortality and highlights serious risks from taking the wrong supplements at the wrong time. What helps in one context can cause harm in another, so the details matter.
Vitamin D and Cancer Mortality
Vitamin D has the most consistent evidence of any vitamin when it comes to cancer outcomes. A meta-analysis of randomized controlled trials published in the Annals of Oncology found that vitamin D supplementation was associated with a 13% reduction in cancer death over follow-up periods of three to ten years. That benefit held across multiple cancer types and was not limited to people with severe deficiency.
The protective effect appeared when blood levels of vitamin D reached a range of roughly 22 to 54 ng/mL. Even people whose levels stayed under 40 ng/mL saw a statistically significant reduction in cancer mortality. This is notable because many adults, particularly those living in northern climates or spending little time outdoors, fall below 20 ng/mL.
Vitamin D did not reduce the number of new cancer diagnoses in these trials. Its benefit was specifically in survival after a cancer developed. The working theory is that vitamin D influences how cancer cells grow, spread, and respond to the immune system rather than preventing the initial DNA damage that starts a tumor.
Folate: Protective or Dangerous, Depending on Timing
Folate, the B vitamin found naturally in leafy greens, legumes, and fortified grains, plays a genuinely dual role in cancer. In healthy tissue, adequate folate helps maintain DNA stability, supports proper DNA repair, and prevents the kind of genetic damage that can trigger tumor formation. Modest folate intake from food appears protective against colorectal cancer in particular.
The problem arises when precancerous cells already exist. In animal studies and at least one large human trial, folate supplementation accelerated the growth of established or precancerous lesions. The Aspirin-Folate Polyp Prevention Study followed over 1,000 people who had previously had precancerous colon polyps removed. Those who took 1 mg of folic acid daily for up to six years were 67% more likely to develop advanced lesions with high malignant potential and more than twice as likely to develop multiple new polyps compared to those on placebo.
The explanation is straightforward: folate provides the raw materials cells need to copy their DNA. Healthy cells use this to function normally. But cancer cells and precancerous growths use the same building blocks to proliferate faster. This is actually why some chemotherapy drugs work by blocking folate metabolism. Supplementing with high-dose folic acid can essentially feed the very cells treatment is trying to starve.
Getting folate from a varied diet is generally fine and likely beneficial. High-dose folic acid supplements are where the risk concentrates, especially for anyone with a history of polyps or colorectal cancer.
B Vitamins and Lung Cancer in Smokers
A study of more than 44,000 men found that smokers who took high doses of vitamin B6 or B12 had three to four times the lung cancer risk compared to smokers who did not supplement. High doses in this context meant 20 mg of B6 per day or 55 micrograms of B12, which are roughly 12 and 23 times the recommended daily intakes for men over 51.
These are the doses commonly found in “mega B-complex” or “energy” supplements, not the amounts in a standard multivitamin. Researchers believe the excess B vitamins may fuel the growth of small, undetected tumors that are common in long-term smokers. Men who had quit smoking for at least ten years before the study did not show the elevated risk, even at high supplement doses. The finding was also specific to men; women in similar studies have not shown the same pattern, though the reasons remain unclear.
Vitamin E: The SELECT Trial Warning
For years, vitamin E was promoted as a cancer-preventive antioxidant. The SELECT trial, one of the largest cancer prevention studies ever conducted, put that idea to rest. Men who took 400 IU of vitamin E daily had a 17% increase in prostate cancer compared to men who took a placebo. The trial was stopped early because of this finding.
This result was particularly striking because it wasn’t a case of “no benefit.” The supplement actively increased risk. The mechanism likely involves vitamin E’s potent antioxidant activity interfering with the body’s normal tumor-suppression processes, which sometimes rely on oxidative stress to kill abnormal cells.
Intravenous Vitamin C: A Different Story Than Oral Supplements
Intravenous vitamin C, administered at doses far beyond what the gut can absorb from pills, has shown some promising results in clinical trials, but it remains experimental. In ovarian cancer patients receiving standard chemotherapy, adding IV vitamin C reduced treatment-related side effects. A 2024 phase II trial in stage IV pancreatic cancer found that IV vitamin C combined with chemotherapy extended both overall survival and the time before the disease progressed, without adding toxicity.
These results are encouraging but come from small trials. IV vitamin C is not the same as taking oral vitamin C supplements, which reach much lower blood concentrations. At intravenous doses, vitamin C behaves more like a pro-oxidant drug than a dietary antioxidant, which is why the biological effects are so different. This therapy is only available through clinical settings and is not a standard recommendation.
Why Antioxidant Supplements Can Backfire During Treatment
Chemotherapy and radiation therapy work, in large part, by generating oxidative stress that damages and kills cancer cells. Antioxidant supplements, including vitamins A, C, and E, are designed to neutralize exactly that kind of damage. When taken during treatment, they can protect cancer cells alongside healthy ones.
Research has shown that oral vitamin C taken alongside certain chemotherapy drugs can reduce the cell-killing activity of those medications by more than 10%. Vitamin C may also shield cancer cells from the effects of hormone-blocking drugs like tamoxifen. Vitamin E reduced radiation damage in head and neck cancer patients but was associated with higher cancer recurrence rates, particularly among smokers. Vitamin A’s cell-repair functions can similarly counteract the intended effects of both chemotherapy and radiation.
This does not mean all vitamins are harmful during treatment. It means that high-dose antioxidant supplements taken without coordination with an oncology team carry a real risk of undermining the treatment itself.
What Oncologists Actually Recommend
The American Society of Clinical Oncology’s position is clear: high-dose vitamin supplementation has not shown conclusive benefits in well-designed randomized trials for cancer patients. Standard-dose vitamins and minerals from a balanced diet are important, but routine supplementation offers no proven benefit except for patients who have inadequate dietary intake or malabsorption issues leading to actual deficiencies.
Cancer and its treatments frequently cause nutritional deficiencies through reduced appetite, nausea, surgical removal of parts of the digestive tract, or direct damage to the gut lining. In these situations, targeted supplementation to correct a measured deficiency is appropriate. There are currently no cancer-specific guidelines for when or how to supplement individual vitamins like B12; deficiencies are managed using the same protocols as for the general population.
The practical takeaway is that vitamins are not uniformly “good for cancer.” Vitamin D at reasonable doses appears to improve cancer survival. Folate from food protects healthy tissue but can accelerate existing growths. High-dose B vitamins and vitamin E can increase specific cancer risks. And antioxidant supplements during active treatment may reduce the effectiveness of chemotherapy and radiation. The safest approach is to maintain good nutrition through food, correct documented deficiencies with your care team, and avoid megadose supplements without a specific, evidence-based reason.